Get the Stockscreener App
66.95
2.50%
-1.72
After Hours:
68.28
1.33
+1.99%
Genedx Holdings Corp stock is traded at $66.95, with a volume of 443.81K.
It is down -2.50% in the last 24 hours and down -15.15% over the past month.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
See More
Previous Close:
$68.67
Open:
$69.95
24h Volume:
443.81K
Relative Volume:
0.64
Market Cap:
$1.96B
Revenue:
$427.54M
Net Income/Loss:
$-21.02M
P/E Ratio:
-90.23
EPS:
-0.742
Net Cash Flow:
$14.26M
1W Performance:
-5.29%
1M Performance:
-15.15%
6M Performance:
-40.73%
1Y Performance:
-33.44%
1-Day Range:
$66.85
$70.62
1-Week Range:
$66.85
$73.64
52-Week Range:
$55.17
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
66.95 | 2.01B | 427.54M | -21.02M | 14.26M | -0.742 |
TMO
Thermo Fisher Scientific Inc
|
490.77 | 182.14B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
187.15 | 134.43B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
575.72 | 45.40B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
112.98 | 32.27B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
302.32 | 29.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-15-25 | Initiated | Guggenheim | Buy |
| May-09-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
View All
Genedx Holdings Corp Stock (WGS) Latest News
Craig-Hallum reaffirms buy on GeneDx (WGS) with $153 price target - MSN
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
GENEDX HOLDINGS (WGS) Raised to Strong Buy: Essential Information You Need - Bitget
GeneDx Holdings Corp. (WGSWW) Stock Price, News, Quote & History - Yahoo! Finance Canada
GENEDX HOLDINGS (WGS) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Craig-Hallum Reaffirms Buy on GeneDx (WGS) With $153 Price Target - Insider Monkey
Is GeneDx (WGS) Using Sponsored NPC Testing to Quietly Strengthen Its Data Advantage? - Yahoo Finance
10 Best Diagnostics and Research Stocks to Buy According to Analysts - Insider Monkey
Avoiding Lag: Real-Time Signals in (WGS) Movement - Stock Traders Daily
Is GeneDx Holdings (WGS) Attractive After Recent Share Price Weakness And DCF Upside? - simplywall.st
Published on: 2026-03-21 10:39:49 - baoquankhu1.vn
GeneDx (WGS), Zevra Therapeutics (ZVRA) partner to launch sponsored genetic testing program for NPC - MSN
GeneDx (WGS), Zevra Therapeutics (ZVRA) Partner to Launch Sponsored Genetic Testing Program for NPC - Insider Monkey
WGS Stock Price, Quote & Chart | GENEDX HOLDINGS CORP (NASDAQ:WGS) - ChartMill
WGSWW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Jefferies reiterates GeneDx stock rating citing data advantage By Investing.com - Investing.com India
Jefferies reiterates GeneDx stock rating citing data advantage - Investing.com UK
GeneDx Holdings Corp. (WGS) Q4 earnings and revenues beat estimates - MSN
GeneDx Holdings Corp (WGS) Stock Price Down 4.09% on Mar 18 - GuruFocus
What do analysts think about GeneDx Holdings Corp. (WGS)? - MSN
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - AOL.com
GeneDx Holdings Corp. Q4 2025 earnings preview - MSN
Down 25% in 4 weeks, here's why GENEDX HOLDINGS (WGS) looks ripe for a turnaround - MSN
Oracle Investment Management Inc. Sells 132,500 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx CFO Feeley sells $438k in shares after option exercise - Investing.com Australia
GeneDx CFO Feeley sells $438k in shares after option exercise By Investing.com - Investing.com India
Insider Selling: GeneDx (NASDAQ:WGS) CEO Sells 17,179 Shares of Stock - MarketBeat
Insider Selling: GeneDx (NASDAQ:WGS) CFO Sells 5,706 Shares of Stock - MarketBeat
GeneDx CEO Stueland sells $1.32 million in WGS stock By Investing.com - Investing.com India
GeneDx CEO Stueland sells $1.32 million in WGS stock - Investing.com
GeneDx Holdings Corp. CEO Katherine Stueland Sells Shares to Cover Tax Obligations - TradingView
GeneDx Holdings Corp. Experiences Revision in Stock Evaluation Amid Market Fluctuations - Markets Mojo
GeneDx (WGS) CEO exercises RSUs, sells 17,179 shares to cover taxes - Stock Titan
GeneDx (WGS) CFO sells shares to cover RSU tax obligations - Stock Titan
Aug Update: What are the risks of holding GeneDx Holdings CorpWeekly Profit Summary & Community Trade Idea Sharing Platform - baoquankhu1.vn
Aug Ideas: What are the risks of holding GeneDx Holdings CorpLong Setup & AI Forecasted Entry and Exit Points - baoquankhu1.vn
GeneDx Holdings Corp - Analytics Insight
GeneDx Holdings Corp. $WGS Stake Lessened by Fred Alger Management LLC - MarketBeat
Farallon Capital Management LLC Sells 321,677 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Casdin Capital LLC Has $323.99 Million Stake in GeneDx Holdings Corp. $WGS - MarketBeat
Portolan Capital Management LLC Has $4.75 Million Stock Holdings in GeneDx Holdings Corp. $WGS - MarketBeat
Genedx Earnings Call Signals Strong Genomics Growth - TipRanks
New Highs: What makes GeneDx Holdings Corp stock attractive today2026 Price Targets & Verified Stock Trade Ideas - baoquankhu1.vn
Quantitative Investment Management Buys Stake in GeneDx - National Today
Quantitative Investment Management LLC Buys New Position in GeneDx Holdings Corp. $WGS - MarketBeat
Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat - MSN
100,284 Shares in GeneDx Holdings Corp. $WGS Bought by Capital International Investors - MarketBeat
Is GeneDx, the Stock Cathie Wood Bought for 7 Straight Days, Actually Cheap? - NAI500
Aug Drivers: Does GeneDx Holdings Corp Equity Warrant stock benefit from AI growth2026 Setups & Technical Pattern Alert System - baoquankhu1.vn
GeneDx Holdings Corp. (WGS) latest stock news and headlines - Yahoo Finance Singapore
GeneDx stock falls as Natera launches competing rare disease test By Investing.com - Investing.com South Africa
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.19%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):